Expertise in
1
conditions

Dr. Daniel M. Lebovic

Pediatrics
326 Main St, 
Metuchen, NJ 
Expertise in
1
conditions
326 Main St, 
Metuchen, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Daniel Lebovic is a Pediatrics provider in Metuchen, New Jersey. Dr. Lebovic is highly rated in 1 condition, according to our data. His top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Classical Hodgkin Lymphoma, and Small Lymphocytic Lymphoma (SLL).

His clinical research consists of co-authoring 16 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatrics
Licenses
Pediatrics in NJ
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

326 Main St, Metuchen, NJ 08840

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment Status: Active_not_recruiting
Publish Date: June 10, 2025
Intervention Type: Drug, Other
Study Drugs: Brentuximab vedotin, Rituximab, Lenalidomide
Study Phase: Phase 3
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Pirtobrutinib, Idelalisib, Bendamustine, Rituximab
Study Phase: Phase 3
A Phase II Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia and Untreated CLL Patients With Genomic Deletion 11q
A Phase II Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia and Untreated CLL Patients With Genomic Deletion 11q
Enrollment Status: Active_not_recruiting
Publish Date: February 26, 2025
Intervention Type: Drug
Study Drug: Metformin
Study Phase: Phase 2
View 2 Less Clinical Trials

16 Total Publications

Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial.
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial.
Journal: JAMA network open
Published: December 05, 2022
Similar Doctors
Expertise in
23
conditions
Dr. Ingo Helbig
Pediatrics | Pediatric Neurology | Neurology
Expertise in
23
conditions
Dr. Ingo Helbig
Pediatrics | Pediatric Neurology | Neurology
3401 Civic Center Blvd, 9nw, Room 55, 
Philadelphia, PA 
 (60.0 mi)
215-590-1220
Languages Spoken:
English

Ingo Helbig is a Pediatrics specialist and a Pediatric Neurologist in Philadelphia, Pennsylvania. Dr. Helbig is highly rated in 23 conditions, according to our data. His top areas of expertise are Epilepsy, West Syndrome, Myoclonic Epilepsy, and Spasmus Nutans.

Expertise in
1
conditions
Dr. Rachel S. Gross
Pediatrics
Expertise in
1
conditions
Dr. Rachel S. Gross
Pediatrics
3444 Kossuth Ave, Family Care Center, Pediatric Practice C, 
Bronx, NY 
 (34.5 mi)
718-920-2655
Languages Spoken:
English

Rachel Gross is a Pediatrics provider in Bronx, New York. Dr. Gross is highly rated in 1 condition, according to our data. Her top area of expertise is Obesity in Children.

Expertise in
1
conditions
Dr. Emanuel M. Dicicco-Bloom
Pediatrics
Expertise in
1
conditions
Dr. Emanuel M. Dicicco-Bloom
Pediatrics
1 Robert Wood Johnson Pl, 
New Brunswick, NJ 
 (5.6 mi)
732-828-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Emanuel Dicicco-Bloom is a Pediatrics provider in New Brunswick, New Jersey. Dr. Dicicco-Bloom is highly rated in 1 condition, according to our data. His top area of expertise is Autism Spectrum Disorder. Dr. Dicicco-Bloom is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lebovic's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile